Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4774509 | 0.75 | DPP4 (0.45) | DPP4F2TSHRCES2CES1 | |
| SCHEMBL1494253 | 0.73 | DPP4 (0.43) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL842216 | 0.73 | DPP4 (0.43) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL1494256 | 0.71 | DPP4 (0.48) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL8386068 | 0.71 | DPP4 (0.41) | DPP4F2TSHRCES2CES1 | |
| SCHEMBL707749 | 0.71 | DPP4 (0.41) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL8381565 | 0.71 | DPP4 (0.41) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL245489 | 0.71 | TSHR (0.48) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL2796779 | 0.71 | DPP4 (0.41) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL434195 | 0.71 | SRC (0.42) | DPP4F2TSHRCES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3092264-B1 | METHOD FOR CAPPING MQ-TYPE SILICONE RESINS | DOW SILICONES CORP (US) | 2019-10-23 | — | — | EP | disclosed |
| US-9732191-B2 | Method for capping MQ-type silicone resins | DOW CORNING CORPORATION (US) | 2017-08-15 | — | — | US | disclosed |
| EP-3092264-A1 | METHOD FOR CAPPING MQ-TYPE SILICONE RESINS | Dow Corning Corporation (US) | 2016-11-16 | — | — | EP | disclosed |
| US-20160326320-A1 | Method For Capping Mq-Type Silicone Resins | DOW COMING CORPORATION (US) | 2016-11-10 | — | — | US | disclosed |
| WO-2015105931-A1 | METHOD FOR CAPPING MQ-TYPE SILICONE RESINS | DOW CORNING CORPORATION (US) | 2015-07-16 | — | — | WO | disclosed |
| US-8791221-B2 | Addition-curable metallosiloxane compound | DAICEL CORPORATION (JP) | 2014-07-29 | — | — | US | disclosed |
| US-20130267653-A1 | ADDITION-CURABLE METALLOSILOXANE COMPOUND | DAICEL CORPORATION (JP) | 2013-10-10 | — | — | US | disclosed |
| US-8404876-B2 | Process for producing nanoparticles | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-03-26 | — | — | US | disclosed |
| EP-2297172-B1 | PROCESS FOR PRODUCING NANOPARTICLES | 3M INNOVATIVE PROPERTIES CO (US) | 2012-06-27 | — | — | EP | disclosed |
| US-8124239-B2 | Silica film forming material, silica film and method of manufacturing the same, multilayer wiring structure and method of manufacturing the same, and semiconductor device and method of manufacturing the same | FUJITSU LIMITED (JP) | 2012-02-28 | — | — | US | disclosed |
| EP-1319666-A1 | Novel antibacterial compounds | Sankyo Company, Limited (JP) | 2003-06-18 | — | — | EP | disclosed |
| EP-1319406-A1 | Novel antibacterial compounds | Sankyo Company, Limited (JP) | 2003-06-18 | — | — | EP | disclosed |
| US-20030069204-A1 | Strain of streptomyces | SANKYO COMPANY LIMITED (JP) | 2003-04-10 | — | — | US | disclosed |
| US-20030055297-A1 | An alkyl, cycloalkyl, arylalkyl dihydroxy compound useful as intermediates; a cost-effective preparation | ABBOTT LABORATORIES | 2003-03-20 | — | — | US | disclosed |
| US-6472384-B1 | Antimicrobial compounds | SANKYO COMPANY, LIMITED (JP) | 2002-10-29 | — | — | US | disclosed |
| WO-2002081441-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRROLIDINE NEURAMINIDASE INHIBITORS | ABBOTT LABORATORIES (US) | 2002-10-17 | — | — | WO | disclosed |
| EP-1095947-A1 | NOVEL ANTIBACTERIAL COMPOUNDS | Sankyo Company Limited (JP) | 2001-05-02 | — | — | EP | disclosed |
| EP-0284473-B1 | PROCESS FOR THE PREPARATION OF SILYLATED CETENE ACETALS | RHONE-POULENC CHIMIE (FR) | 1991-05-29 | — | — | EP | disclosed |
| EP-0284473-A1 | Process for the preparation of silylated cetene acetals | RHONE-POULENC CHIMIE (FR) | 1988-09-28 | — | — | EP | disclosed |
| US-4151327-A | WATER AND OIL REPELLANT, DIMENSIONAL STABILITY, CLARITY OR OPACITY | LAWTON WILLIAM R | 1979-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069204-A1 | Strain of streptomyces | O60361, CYP8B1, MRPS34 | DPP4 1598/4885F2 4297/4885TSHR 3757/4885 |
| US-20030055297-A1 | An alkyl, cycloalkyl, arylalkyl dihydroxy compound useful as intermediates; a cost-effective preparation | NEU4, NEU2, NEU1 | DPP4 97/4885F2 2991/4885TSHR 762/4885 |
| US-20130267653-A1 | ADDITION-CURABLE METALLOSILOXANE COMPOUND | B2M, MSI2, MNS1 | DPP4 4193/4885F2 1288/4885TSHR 4702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.